LifeScience Clinical & Diagnostic
- 13-week U.S. Phase II study is evaluating the efficacy, safety and tolerability of oral small molecule GLP-1R agonist ASC30, a once-d...
April 27, 2026 | News
The new Chonburi facility increases global manufacturing capacity and strengthens regional supply chain capabilities for leading MedTech customers Quasar ...
April 27, 2026 | News
Regulatory Filing in Japan Planned Following Clinical Trial Completion – Kyowa Kirin Co., Ltd. (TSE: 4151, “Kyowa Kirin”) and Kura...
April 27, 2026 | News
AscendCare Medical Clinic, a modern healthcare provider based in Tanjong Pagar, today announced a new public education initiative designed to reframe healt...
April 24, 2026 | News
Everest Medicines announced that the first-in-human (FIH) clinical trial data of EVM16, a proprietary personalized mRNA cancer vaccine, were presen...
April 24, 2026 | News
Strategic entry into high-growth Vietnam market Combines Dawn's product sourcing capabilities with Pinnacle Health's established local presence and mark...
April 23, 2026 | News
Completed Projects Further Support the Company's Transition Toward High-Margin, Solution-Driven Revenue and Strengthen Customer Stickiness Across AI Multim...
April 22, 2026 | News
SynSmart Rasayan Research Private Limited and Amporin Pharmaceuticals AG announced a collaboration to develop breakthrough small molecule therapeutic...
April 22, 2026 | News
Orthogon Therapeutics announced the closing of an $11 million follow-on financing, bringing the total capital raised to $36 million. The financing will ena...
April 21, 2026 | News
A next-generation PCR system designed to help labs manage increasing workflow complexity with greater flexibility, speed and confidence in reproducible res...
April 17, 2026 | News
Perceptive Discovery announced a strategic partnership with MH3D alongside the launch of α-Sight™, a new preclinical imaging offering enabling ...
April 17, 2026 | News
Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the National Medical Products Ad...
April 17, 2026 | News
DualityBio announced that the Biologics License Application (BLA) for the investigational antibody-drug conjugate ("ADC") trastuzumab pamirtecan ("T-Pam", ...
April 14, 2026 | News
Haisco Pharmaceutical Group Co., Ltd. (Ticker Code: 002653) announced that it has entered into an exclusive licensing agreement with AbbVie (NYSE: ABBV), a...
April 14, 2026 | News
Most Read
Bio Jobs
News
Editor Picks